Importance Poor diet is a leading global factor associated with cardiometabolic disease
(CMD). Understanding the quality of evidence of the associations between specific dietary …

Foundational therapy for heart failure and a reduced ejection fraction consists of a
combination of an angiotensin receptor–neprilysin inhibitor, a betablocker, a …

Aims The aim of this study was to examine the effect of dapagliflozin on the incidence of
ventricular arrhythmias and sudden death in patients with heart failure and reduced ejection …

Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …

Introduction Multiple randomized controlled trials have demonstrated sodiumglucose
cotransporter2 inhibitors (SGLT2i) decrease the composite endpoint of cardiovascular …

Aims Finerenone reduces the risk of cardiovascular events in patients with chronic kidney
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …

Heart failure (HF) characterized by cardiac remodeling is a condition in which inflammation
and fibrosis play a key role. Dietary supplementation with n-3 polyunsaturated fatty acids …

Numerous guideline documents have issued recommendations to clinicians concerning the
treatment of chronic heart failure and a reduced ejection fraction. However, guidelines do …

Aims Sudden death is a leading cause of mortality in heart failure with reduced ejection
fraction (HFrEF). In PARADIGMHF, sacubitril/valsartan reduced the incidence of sudden …

The impact of sudden cardiac death (SCD) in heart failure (HF) patients is important and
prevention of SCD is a reasonable and clinically justified endpoint if associated with a …